Cervicovaginal microbiota and local immune response modulate the risk of spontaneous preterm delivery.
Elovitz MA, Gajer P, Riis V, Brown AG, Humphrys MS, Holm JB, Ravel J. · 2019
Read Cervicovaginal microbiota and local immune response modulate the risk of spontaneous preterm delivery. by Elovitz MA, Gajer P, Riis V, Brown AG, Humphrys MS, Holm JB, Ravel J. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6428888.txt.
Introduction
Elovitz and co-authors study how vaginal microbes and local immune defenses together shape the risk of spontaneous preterm birth. From a cohort of 2,000 pregnant women, they compared 107 women who delivered early with 432 who delivered at term. Preterm birth remains a leading cause of newborn death, and prediction has been poor.
Bayesian modeling tied seven bacterial taxa to higher risk, with stronger effects in African American women. Higher levels of the immune peptide β-defensin-2 lowered that risk, though the pattern varied by group. Low β-defensin-2 raised risk even when protective Lactobacillus species dominated. Early screening and immune or microbiome therapies are the practical hopes raised.
Catalog record
| CREATOR | Elovitz MA, Gajer P, Riis V, Brown AG, Humphrys MS, Holm JB, Ravel J. |
|---|---|
| YEAR | 2019 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Cervicovaginal microbiota and local immune response modulate the risk of spontaneous preterm delivery By Michal A Elovitz, Pawel Gajer, Valerie Riis, Amy G Brown, Michael S Humphrys, Johanna B Holm, Jacques Ravel Published in: Nature Communications DOI: 10.1038/s41467-019-09285-9 ABSTRACT Abstract Failure to predict and understand the causes of preterm birth, the leading cause of neonatal morbidity and mortality, have limited effective interventions and therapeutics. From a cohort of 2000 pregnant women, we performed a nested case control study on 107 well-phenotyped cases of spontaneous preterm birth (sPTB) and 432 women delivering at term. Using innovative Bayesian modeling of cervicovaginal microbiota, seven bacterial taxa were significantly associated with increased risk of sPTB, with a stronger effect in African American women. However, higher vaginal levels of β-defensin-2 lowered the risk of sPTB associated with cervicovaginal microbiota in an ethnicity-dependent manner. Surprisingly, even in Lactobacillus spp. dominated cervicovaginal microbiota, low β-defensin-2 was associated with increased risk of sPTB. These findings hold promise for diagnostics to accurately identify women at risk for sPTB early in pregnancy. Therapeutic strategies could include immune modulators and microbiome-based therapeutics to reduce this significant health burden. INTRODUCTION Preterm birth (PTB) (defined as birth before 37 completed weeks of gestation) is the leading cause of death in neonates and children under the age of 51,2. Every year worldwide, 1.1 million babies die from consequences of prematurity. PTB occurs in one out of every 10 pregnant women in the United States and over 65–75% of all PTBs are spontaneous with the idiopathic onset of cervical change, uterine contractility and/or rupture of fetal membranes, while the remaining PTBs are medically indicated for reasons such as preeclampsia or fetal distress3. The economic burden of preterm birth is staggering, with an estimated cost of $26 billion per year in the United States alone4,5. While there is known racial disparity in spontaneous preterm birth (sPTB) with African-American women having significantly higher rates than non-African American women, factors that underpin this disparity remain elusive6. While there are medical, societal, and economic costs to the actual PTB, the larger cost to our society stems from the need for long-term care for these preterm infants7. Ex-preterm children are at increased risk for a spectrum of neurobehavioral disorders—ranging from cognitive deficits to cerebral palsy to neurobehavioral abnormalities including autism8–10. A failure to understand the causes of PTB have limited effective interventions and therapeutics. The interaction between microbial communities and their host, in many biological niches, has been found to be mechanistically involved in health and disease pathogenesis11–17. To date, there have been a few studies that have examined the relationship between cervicovaginal microbial communities and sPTB18–22. Definitive conclusions from these studies are difficult to establish as phenotyping of sPTB is heterogenous, the number of sPTB cases is significantly limited and methodology is variable. Here, to overcome sample size limitations, misclassification of cases and methodological differences, we conducted a study involving a prospective cohort of 2000 women with singleton pregnancies called Motherhood & Microbiome (M&M) and tested associations of cervicovaginal microbial communities and local immunological features with sPTB. A nested 1:4 case control study on 107 well-phenotyped cases of sPTB and 432 women delivering at term as control, and frequency matched for race, was performed after enrollment was completed and all delivery adjudicated (Table 1 and Supplementary Table 1). The population studied was mostly African American (AA) (74.5%) with a mean maternal age of around 28 years old. Characteristics associated with sPTB were statistically different, including history of sPTB or second trimester loss, cervical length, cerclage, and vaginal bleeding in the second trimester, while no other demographic, behaviors or clinical factors were different between the cases and controls at baseline and at each visit (Table 1 and Supplementary Table 1). Cervicovaginal samples and anthropometric measurements were prospectively collected during three clinical visits between 16–20 (visit 1), 20–24 (visit 2), and 24–28 (visit 3) weeks of gestation. The cervicovaginal microbiota was characterized and immunological profiles established. [Table: M&M participants demographics and characteristics] RESULTS Cervicovaginal community state types sPTB We identified six major cervicovaginal community state types (CSTs)23, of which four were predominated by either Lactobacillus crispatus (CST I), Lactobacillus gasseri (CST II), Lactobacillus iners (CST III) or Lactobacillus jensenii (CST V), and two (CST IV-A and CST IV-B) comprised a wide array of strict and facultative bacterial anaerobes, where CST IV-A was characterized with the higher abundance of BVAB1. The frequency of CSTs (Supplementary Table 2) was significantly different in AA and non-African American (non-AA) women (Fig. 1a). At visit 1, 20% and 45% of AA women were in CST I or CST IVA/IVB, as compared to 50% and ~15% of non-AA women, respectively. These differences persisted at visit 2 and visit 3 (Supplementary Fig. 1a). The frequency of CST III was higher in AA women at visit 3. Conversely, CST V was consistently lower in AA than in non-AA women throughout the study. When considering all women in the study at visit 1, CST IV-B was statistically significantly higher in the sPTB group than in the term group (Fig. 1b). Interestingly, in non-AA women a statistically significant association between CST IV-B and sPTB was observed when all visits were considered, at visit 1 and 2 (Fig. 1b and Supplementary Fig. 1b). This association was absent in African American women (Fig. 1b) at all study visits. In non-AA women, higher frequency of CST V was associated with term pregnancy, while the opposite was shown in AA women, however, the frequency of this CST was low in the cohort. These findings point to different contributions of the cervicovaginal microbiota to sPTB in AA and non-AA pregnant women, a hypothesis we thus addressed and considered in all analyses. [Figure: Vaginal microbiota composition and structure and risk of sPTB. a Frequency of each CST in non-AA and AA pregnant women when considering samples collected at all three visits or visit 1 (16–20 weeks of gestation). b Frequency of each CST stratified by outcomes (sPTB vs term) in all subjects, non-AA and AA when considering samples collected at all three visits or visit 1 alone. n represents the number of samples included in the analysis. For (a) and (b) p-values were estimated using mixed effects Poisson regression models (all visits) or ordinary logistic regression models (single visit) (c) Volcano plot for seven bacterial taxa statistically significantly associated with increased risk of sPTB in all subjects (red) and AA (blue) showing the effect size on the x-axis and the strength of the association on the y-axis. The gray horizontal lines indicate q-value of 0.05. The median relative abundance of each phylotype is indicated by the size of the point. Dependence of the risk of sPTB (defined as <37 weeks of gestation) on the log10 relative abundance of M. curtisii/mulieris and S. sanguinegens in all subjects and AA is shown on the right. Effect size is the difference between the lowest and highest probability of sPTB. Greyed area indicates 95% credible region. Dotted line corresponds to the significant risk of sPTB threshold values (taxa log10 relative abundance above which the risk is significant different from baseline). n represents the number of samples in which the bacterial taxon was detected and included in the analysis. (d) is the